Goldman Sachs’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Goldman Sachs’s Portfolio SRTAW Stock Details SRTAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,679,523	Closed	-$284K	–	5823
2024 Q2	$284K	Sell	1,679,523 -620,477	-27%	-$159K	﹤0.01%	5131
2024 Q1	$240K	Hold	2,300,000	–	–	﹤0.01%	5054
2023 Q4	$805K	Hold	2,300,000	–	–	﹤0.01%	4507
2023 Q3	$529K	Hold	2,300,000	–	–	﹤0.01%	4635
2023 Q2	$1.46M	Hold	2,300,000	–	–	﹤0.01%	4095
2023 Q1	$1.1M	Hold	2,300,000	–	–	﹤0.01%	4319
2022 Q4	$1.15M	Hold	2,300,000	–	–	﹤0.01%	4336
2022 Q3	$1.47M	Hold	2,300,000	–	–	﹤0.01%	4223
2022 Q2	$1.54M	Hold	2,300,000	–	–	﹤0.01%	4283
2022 Q1	$4.67M	Hold	2,300,000	–	–	﹤0.01%	3419
2021 Q4	$5.08M	Hold	2,300,000	–	–	﹤0.01%	3391
2021 Q3	$6.85M	Hold	2,300,000	–	–	﹤0.01%	3083
2021 Q2	$6.3M	Hold	2,300,000	–	–	﹤0.01%	3132
2021 Q1	$5.75M	Buy	2,300,000 +1,555,000	+209%	+$5.69M	﹤0.01%	3007
2020 Q4	$1.82M	Buy	+745,000	New	+$979K	﹤0.01%	3795

Other funds holding SRTAW

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

TPCW

TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Goldman Sachs's SRTAW Position: Q3 2024 in Review

Goldman Sachs sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q3 2024, closing a stake of 1,679,523 shares — an estimated $284K sold.

Goldman Sachs first reported a position in SRTAW in Q4 2020 and held it in 15 quarters. The position peaked at $6.85M in Q3 2021. 8 funds tracked by Wall St. Rank hold SRTAW as of Q3 2024.

Goldman Sachs reported no remaining Strata Critical Medical Inc Warrants position as of Q3 2024 after selling out during the quarter.
Goldman Sachs sold 1,679,523 Strata Critical Medical Inc Warrants shares in Q3 2024, an estimated $284K.
Goldman Sachs first reported a position in Strata Critical Medical Inc Warrants in Q4 2020 and held it in 15 quarters.
Goldman Sachs's Strata Critical Medical Inc Warrants position peaked at $6.85M in Q3 2021.
8 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q3 2024.

Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.